Amarin Corp PLC(AMRN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AMRN Amarin Corp PLC

Trading 10-29 13:47:23 EDT

12.94

+0.19

+1.49%

High13.18	Low12.80	Vol22.57K
Open12.87	D1 Closing12.75	Amplitude2.98%
Mkt Cap273.22M	Tradable Cap251.10M	Total Shares21.12M
T/O292.78K	T/O Rate0.12%	Tradable Shares19.41M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AMRN","market":"US","secType":"STK","nameCN":"Amarin Corp PLC","latestPrice":12.935,"timestamp":1793295554704,"preClose":12.745,"halted":0,"volume":22565,"delay":0,"changeRate":0.014907806983130741,"floatShares":19412400,"shares":21122834,"eps":-1.298704,"marketStatus":"Trading","change":0.19,"latestTime":"10-29 13:47:23 EDT","open":12.87,"high":13.18,"low":12.8001,"amount":292776.63278,"amplitude":0.029808,"askPrice":12.9,"askSize":200,"bidPrice":12.67,"bidSize":203,"shortable":3,"etf":0,"ttmEps":-1.298704,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1793304000000},"marketStatusCode":2,"adr":1,"adrRate":20,"listingDate":733640400000,"exchange":"NASDAQ","adjPreClose":12.745,"preHourTrading":{"tag":"盘前","latestPrice":13.58,"preClose":12.745,"latestTime":"09:09 EDT","volume":4,"amount":53.56,"timestamp":1793279392789,"change":0.835,"changeRate":0.065516,"amplitude":0.029816},"postHourTrading":{"tag":"盘后","latestPrice":12.745,"preClose":12.745,"latestTime":"19:30 EDT","volume":28,"amount":356.53,"timestamp":1793230200951,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.43325,"impliedVol":0.4478,"impliedVolPercentile":0.1554},"requestUrl":"/m/hq/s/AMRN","defaultTab":"news","newsList":[{"id":"2679101574","title":"Amarin (AMRN) Q3 2026 Earnings Call: Profitability Returns as International Demand Grows","url":"https://stock-news.laohu8.com/highlight/detail?id=2679101574","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679101574?lang=en_us&edition=fundamental","pubTime":"2026-10-29 05:50","pubTimestamp":1793224230,"startTime":"0","endTime":"0","summary":"Amarin Q3 2026 earnings call: $39.6 million revenue, first quarterly profit in two years, $9 million operating cash flow and strong international demand.","market":"fut","thumbnail":"https://resource.tradingkey.com/cdn/images/article/news/stock2.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cdn/images/article/news/stock2.jpg"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/transcripts/262249301-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679414722","title":"LENZ Therapeutics Q3 VIZZ Sales Jump 50% Sequentially on Strong Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2679414722","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679414722?lang=en_us&edition=fundamental","pubTime":"2026-10-29 04:39","pubTimestamp":1793219984,"startTime":"0","endTime":"0","summary":"LENZ Therapeutics Q3 VIZZ sales jump 50% sequentially on strong demandOverviewU.S. pharmaceutical firm's Q3 VIZZ product sales rose 50% over prior quarter on growing demandCompany posted Q3 net loss o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nL2N46E1IV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","AMRN","LENZ","BK4139","BK4539","LU1878469433.USD","VNDA","GKOS","BK4082","LU2065731478.USD","BK4007","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678949448","title":"European Equities Traded in the US as American Depositary Receipts Steady in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2678949448","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678949448?lang=en_us&edition=fundamental","pubTime":"2026-10-28 23:15","pubTimestamp":1793200536,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were little changed around 1,893.13 on the S&P Europe Select ADR Index late Wednesday morning.From continental Europe, the gainers were led by biopharmaceutical companies Cellectis  and DBV Technologies , which advanced 17% and 3.2% respectively. They were followed by healthcare tech firm Royal Philips  and medical device maker EDAP TMS , which increased 2.2% and 1.7% respectively.The decliners from continental Europe were led by 3D printer company Materialise  and lender Banco Santander , which dropped 22% and 5% respectively. They were followed by consumer goods company Unilever , which lost 1.7%.The gainers from the UK and Ireland were led by Amarin  and Biodexa Pharmaceuticals , which rose 5.9% and 5.5% respectively. They were followed by Akari Therapeutics  and Autolus Therapeutics , which were up 5.1% and 1.6% respectively.The decliners from the UK and Ireland were led by pharmaceutical company GSK  and biopharmac","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSK.UK","GSIB","BK4168","BK4207","DBVT","LU0084288595.USD","LU1829250122.USD","BK4532","LU0300736492.USD","PHG","DAVA.AU","UL","ULVR.UK","BK4183","BK4592","UN","BK4117","BK7095","BK4521","SAN","BDRX","BK4585","BHP","GSK","LU0124676726.USD","BHP.AU","COAL","BK4139","AKTX","AFG","AMRN","BK4588","BK4082","SLX","AUTL","CLLS","MTLS","PRNT","DAVA","FOCL","SAN.AU","BK7142","GSKH","BK7507","LU0689626769.HKD","LU0300736062.USD","EPV","IEUR","NCNA","LU0648005311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678949958","title":"Amarin Corporation PLC Reports Results for the Quarter Ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2678949958","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678949958?lang=en_us&edition=fundamental","pubTime":"2026-10-28 22:10","pubTimestamp":1793196652,"startTime":"0","endTime":"0","summary":"Amarin Corporation PLC reports results for the quarter ended September 30 - Earnings SummaryAmarin Corporation PLCAMRN.OQreported quarterly adjusted earnings of 8 cents per share for the quarter ended","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nL5N46E255:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678346455","title":"Amarin Expects Positive Cash Flow for Full-Year 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2678346455","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678346455?lang=en_us&edition=fundamental","pubTime":"2026-10-28 19:31","pubTimestamp":1793187110,"startTime":"0","endTime":"0","summary":"Amarin Expects Positive Cash Flow for Full-Year 2026Amarin expects positive cash flow for full-year 2026, supported by a lower operating cost base.Restructuring completed in the second quarter generat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nNDL9MHcM7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678617834","title":"Amarin Q3 Revenue Falls 20% on US Pricing Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=2678617834","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678617834?lang=en_us&edition=fundamental","pubTime":"2026-10-28 19:23","pubTimestamp":1793186580,"startTime":"0","endTime":"0","summary":"Amarin Q3 revenue falls 20% on US pricing pressureOverviewCardiovascular drug maker's Q3 revenue fell 20% yr/yr, mainly due to lower U.S. salesCompany posted first quarterly profit in over two years a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nL2N46E0J1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678446131","title":"Amarin Swings to Q3 2026 Net Income of $245,000 from Year-Earlier Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2678446131","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678446131?lang=en_us&edition=fundamental","pubTime":"2026-10-28 19:13","pubTimestamp":1793186029,"startTime":"0","endTime":"0","summary":"Amarin swings to Q3 2026 net income of $245,000 from year-earlier lossAmarin swung to net income of $245,000 in Q3 2026, its first profitable quarter in over two years.Total net revenue fell 20% year ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nNDL2Q5rQW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","SG9999014005.SGD","BK4139","IE00BQXX3D17.EUR","LU2210149790.SGD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BCDF","LU2210150020.SGD","BK4585","IE00BQXX3C00.GBP","IE00BKPKM429.USD","SG9999014039.USD","SG9999014013.SGD","IE00BN0W2T93.GBP","LU0314104364.USD","LU2095319765.USD","AMRN","BK4112","IE00BGHQF748.EUR","NDAQ","SG9999014021.USD","IE00BN0W2V16.EUR","BK4588","IE00BQXX3F31.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678469632","title":"Amarin Corp Q3 Adj. EPS $0.08 Beats $(0.02) Estimate, Sales $39.550M Miss $43.711M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2678469632","media":"Benzinga Earnings","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678469632?lang=en_us&edition=fundamental","pubTime":"2026-10-28 19:00","pubTimestamp":1793185246,"startTime":"0","endTime":"0","summary":"Amarin Corp (NASDAQ:AMRN) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.02) by 500 percent. This is a 57.89 percent decrease over earnings of $0.19 per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/10/62647971/amarin-corp-q3-adj-eps-0-08-beats-0-02-estimate-sales-39-550m-miss-43-711m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678667374","title":"Amarin Reports 2026 Third Quarter Financial Results, Achieves Positive Net Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2678667374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678667374?lang=en_us&edition=fundamental","pubTime":"2026-10-28 19:00","pubTimestamp":1793185205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nTUA90H4NM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678619294","title":"Amarin: Q3 Total Net Revenue $39.6 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2678619294","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678619294?lang=en_us&edition=fundamental","pubTime":"2026-10-28 19:00","pubTimestamp":1793185205,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nPLX9PWWPT:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AMRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678466722","title":"Amarin Q3 Operating Income USD -2.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2678466722","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678466722?lang=en_us&edition=fundamental","pubTime":"2026-10-28 19:00","pubTimestamp":1793185205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nPLX9PWWPT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678144461","title":"Amarin: Q3 Non-Gaap Earnings Per Ads $0.08","url":"https://stock-news.laohu8.com/highlight/detail?id=2678144461","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678144461?lang=en_us&edition=fundamental","pubTime":"2026-10-28 19:00","pubTimestamp":1793185205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nPLX9PWWPT:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AMRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678968811","title":"Amarin Corporation PLC Expected to Post a Loss of 2 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2678968811","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678968811?lang=en_us&edition=fundamental","pubTime":"2026-10-26 21:03","pubTimestamp":1793019800,"startTime":"0","endTime":"0","summary":"Amarin Corporation PLC <AMRN.OQ> expected to post a loss of2cents a share - Earnings PreviewAmarin Corporation PLCAMRN.OQAMRN.Ois expected to  show a fall in quarterly revenue when it reports  results on October 28 for the period ending September 30 2026The Dublin Ireland-based   company is expected to report a 12.0% decrease in revenue to $43.711 million from $49.67 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.LSEG's mean analyst estimate for Amarin Corporation PLC is for a loss of 2 cents per share.The current average analyst rating on the shares is \"sell\" and the breakdown of recommendations is no \"strong buy\" or \"buy,\" no \"hold\" and 2 \"sell\" or \"strong sell.\"The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Amarin Corporation PLC is $12.00, about 1.8% above its last closing price of $11.79This summary was machine generated October 26 at 13:03 GMT.  All figures in US","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261026:nL5N46C13T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678913995","title":"Amarin announces EPA for Metastasis Trial 2 did not meet primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2678913995","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678913995?lang=en_us&edition=fundamental","pubTime":"2026-10-26 04:35","pubTimestamp":1792960510,"startTime":"0","endTime":"0","summary":"Amarin (AMRN) highlighted findings from the EPA for Metastasis Trial 2, EMT2, a randomized, double-blind, placebo-controlled, multi-center, Phase 3...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amarin-announces-epa-for-metastasis-trial-2-did-not-meet-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amarin-announces-epa-for-metastasis-trial-2-did-not-meet-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678213842","title":"Amarin's Vascepa Misses Primary Endpoint in Phase 3 Colorectal Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2678213842","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678213842?lang=en_us&edition=fundamental","pubTime":"2026-10-25 20:11","pubTimestamp":1792930289,"startTime":"0","endTime":"0","summary":"Amarin's Vascepa misses primary endpoint in Phase 3 colorectal cancer trialAmarin reported Phase 3 EMT2 results showing VAZKEPA/VASCEPA missed its primary goal of delaying cancer progression but impro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261025:nNDLbtHhSQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","LU2095319765.USD","NDAQ","LU0314104364.USD","BK4585","LU2210150020.SGD","IE00B64PRP62.GBP","SG9999014005.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","IE00BQXX3F31.USD","BCDF","IE00BQXX3D17.EUR","AMRN","SG9999014021.USD","BK4588","SG9999014039.USD","BK4139","LU2210149790.SGD","IE00BKPKM429.USD","IE00BQXX3C00.GBP","IE00BN0W2W23.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678382771","title":"Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patients Undergoing Liver Resection for Colorectal Cancer Liver Metastases (CRCLM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2678382771","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678382771?lang=en_us&edition=fundamental","pubTime":"2026-10-25 20:11","pubTimestamp":1792930260,"startTime":"0","endTime":"0","summary":"Pre-specified and Statistically Powered Key Endpoints Included Progression-free Survival (PFS) and Overall Survival (OS). Although Primary Endpoint of PFS Was Not Met, TheKey Secondary Endpoint of OS ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/25/3387729/18362/en/amarin-provides-update-on-university-of-leeds-sponsored-phase-3-epa-for-metastasis-trial-2-emt2-evaluating-vazkepa-vascepa-icosapent-ethyl-capsules-on-top-of-standard-of-care-treat.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4090","SMP","IPE","BK4161","AMRN","BK4211","BK4139","LU0054578231.USD","VGT","TG","BK4195","LU0053671581.USD","BK4124","BK4588","PFS","ITT","BK4153","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677708676","title":"Amarin Updates Financial Calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2677708676","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677708676?lang=en_us&edition=fundamental","pubTime":"2026-10-21 20:05","pubTimestamp":1792584340,"startTime":"0","endTime":"0","summary":"Amarin updates financial calendarAmarin will release third-quarter 2026 financial results before the market opens on Oct. 28, 2026.Senior management will host a conference call at 8 a.m. ET that day.D","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nNDL62kj7F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4139","IE00BN0W2V16.EUR","SG9999014021.USD","BK4112","IE00BKPKM429.USD","IE00BQXX3D17.EUR","IE00B3QW5Z07.USD","SG9999014005.SGD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","BK4585","IE00B64PRP62.GBP","LU0314104364.USD","LU2210150020.SGD","SG9999014013.SGD","IE00BQXX3C00.GBP","AMRN","BCDF","IE00BN0W2T93.GBP","IE00BQXX3F31.USD","BK4588","NDAQ","LU2210149790.SGD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677676062","title":"Amarin to Report Third Quarter 2026 Financial Results and Host Conference Call on October 28, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2677676062","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677676062?lang=en_us&edition=fundamental","pubTime":"2026-10-21 20:00","pubTimestamp":1792584000,"startTime":"0","endTime":"0","summary":"DUBLIN and BRIDGEWATER, N.J., Oct.  21, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company advancing the science of cardiovascular therapeutics worldwide, today announced that i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/21/3385450/18362/en/amarin-to-report-third-quarter-2026-financial-results-and-host-conference-call-on-october-28-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676682969","title":"European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2676682969","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676682969?lang=en_us&edition=fundamental","pubTime":"2026-10-19 23:13","pubTimestamp":1792422833,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts opened the week lower late Monday morning, declining 0.65% to 1,891.99 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion  and medical device maker EDAP TMS , which advanced 13% and 2.2% respectively. They were followed by internet browser company Opera  and telecommunications company Nokia , which increased 1.1% and 0.9% respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis  and pharmaceutical company Sanofi , which dropped 4.8% and 2.1% respectively. They were followed by petroleum refiner Equinor  and telecommunications company Ericsson , which lost 1.9% and 1.7% respectively.The gainers from the UK were led by pharmaceutical company Silence Therapeutics  and biopharmaceutical company Akari Therapeutics , which surged 125% and 14% respectively. They were followed by biopharmaceutical companies Amarin  and Mereo BioPharm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NOK","AKTX","BK4007","BK4107","IE00BMPRXR70.SGD","BK4023","IE00BMPRXN33.USD","BK4547","BK4207","IE00BFXG1179.USD","EQNR","BK4139","LU0084288595.USD","BCS","NGG","BK4521","LU0648005311.SGD","IEUR","DAVA.AU","LFGY","CLLS","AMRN","BK4213","BK4515","AFG","BDRX","FOCL","OPRA","BK4554","BK4117","MREO","LU0006061336.USD","BK4585","BK4134","BK4020","EPV","EVAX","BK4588","BK4208","BK4082","BK4201","SLN","LNOK","BK4591","DAVA","ALTX","ERIC","BK4505","SNY","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674806452","title":"European Equities Traded in the US as American Depositary Receipts Open Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2674806452","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674806452?lang=en_us&edition=fundamental","pubTime":"2026-10-12 23:14","pubTimestamp":1791818092,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week modestly higher late Monday morning, rising 0.19% to 1,884.14 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by petroleum refiner Equinor  and oil and gas company Eni , which increased 2% and 1.5% respectively. They were followed by medical device maker EDAP TMS  and healthcare tech company Royal Philips , which were up 1.9% and 1.3% respectively.The decliners from continental Europe were led telecommunications company Nokia  and biopharmaceutical company DBV Technologies , which dropped 3% and 2.8% respectively. They were followed by biopharmaceutical company Cellectis  and telecommunications company Ericsson , which lost 4% and 1.7% respectively.The gainers from the UK were led by alcoholic beverage company Diageo  and lender HSBC , which advanced 1.3% and 1.4% respectively. They were followed by oil and gas companies Shell  and BP , which rose 1.4% and 1.2% respectiv","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EPV","XES","BPH","AFG","FOCL","LU0052756011.USD","SHEH","FTXN","IEUR","EQNR","SHEL","DRIP","DRLL","AKTX","BDRX","MREO","AMRN","GUSH","ERIC","IE00BMPRXN33.USD","BK4588","DBVT","ERX","LU0211326839.USD","BP","LNOK","BK4554","LU1829250122.USD","HSBC","IXC","LU0098860793.USD","NOK","VDE","WTIU","DEO","DBE","PHG","DGE.UK","USE","HSBH","PXJ","PXE","DBC","CLLS","LU0320765646.SGD","DIG","E","IEO","LU1267930227.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amarincorp.com","stockEarnings":[{"period":"1week","weight":0.1073},{"period":"1month","weight":-0.0381},{"period":"3month","weight":-0.1044},{"period":"6month","weight":-0.0942},{"period":"1year","weight":-0.3271},{"period":"ytd","weight":-0.0867}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0088},{"period":"3month","weight":0.0413},{"period":"6month","weight":0.0717},{"period":"1year","weight":0.1241},{"period":"ytd","weight":0.1326}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.","yearOnYearQuotes":[{"month":1,"riseRate":0.515152,"avgChangeRate":0.121922},{"month":2,"riseRate":0.272727,"avgChangeRate":-0.050693},{"month":3,"riseRate":0.484848,"avgChangeRate":0.002821},{"month":4,"riseRate":0.424242,"avgChangeRate":0.057152},{"month":5,"riseRate":0.382353,"avgChangeRate":-0.011028},{"month":6,"riseRate":0.5,"avgChangeRate":0.005489},{"month":7,"riseRate":0.242424,"avgChangeRate":-0.032454},{"month":8,"riseRate":0.545455,"avgChangeRate":0.060342},{"month":9,"riseRate":0.424242,"avgChangeRate":0.073417},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.047759},{"month":11,"riseRate":0.5625,"avgChangeRate":0.109863},{"month":12,"riseRate":0.4375,"avgChangeRate":-0.023149}],"exchange":"NASDAQ","name":"Amarin Corp PLC","nameEN":"Amarin Corp PLC","securityTypeName":"DR","adrRate":"1:20"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amarin Corp PLC(AMRN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Amarin Corp PLC(AMRN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Amarin Corp PLC,AMRN,Amarin Corp PLC股票,Amarin Corp PLC股票老虎,Amarin Corp PLC股票老虎国际,Amarin Corp PLC行情,Amarin Corp PLC股票行情,Amarin Corp PLC股价,Amarin Corp PLC股市,Amarin Corp PLC股票价格,Amarin Corp PLC股票交易,Amarin Corp PLC股票购买,Amarin Corp PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amarin Corp PLC(AMRN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Amarin Corp PLC(AMRN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}